Results 151 to 160 of about 2,222,749 (351)
Background Copy number variation (CNV) is a key genetic characteristic for cancer diagnostics and can be used as a biomarker for the selection of therapeutic treatments.
Daniall Masood +25 more
doaj +1 more source
National Drug Information Center Program at Ministry of Health in Saudi Arabia
Yousef Ahmed Alomi
openalex +1 more source
Comparison of information obtained from a Usenet newsgroup and from drug information centers [PDF]
James A. Seaboldt, Randy L. Kuiper
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Relationship Between Time Consumption and Quality of Responses to Drug-related Queries: A Study From Seven Drug Information Centers in Scandinavia [PDF]
Linda Amundstuen Reppe +7 more
openalex +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source
Sadia Awan, Sadais Ahmed, Rabbia Aslam, Aleeha Afzal, Maria Shafaqat, Hadiqa Arif, Mobeen Ahmad, Waleed Maqbool, Syed Muzzammil Masaud, Hafiz Aamir Ali Kharl
openalex +2 more sources
Legislating for the Provision of Comprehensive Substance Abuse Treatment Programs for Pregnant and Mothering Women [PDF]
Additionally, in writing this article it became clear that, although the data collection in this area has improved over the past twenty years, more specific data is needed in order to have a clearer picture of the exact nature of the unmet need so that ...
Rieckman, Traci, PhD +1 more
core +1 more source
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz +12 more
wiley +1 more source

